WallStSmart

CareCloud, Inc. (CCLD)vsTempus AI, Inc. Class A Common Stock (TEM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Tempus AI, Inc. Class A Common Stock generates 1013% more annual revenue ($1.43B vs $128.64M). CCLD leads profitability with a 6.2% profit margin vs -17.8%. CCLD earns a higher WallStSmart Score of 51/100 (C-).

CCLD

Buy

51

out of 100

Grade: C-

Growth: 4.0Profit: 6.0Value: 8.7Quality: 4.5
Piotroski: 3/9Altman Z: 2.20

TEM

Avoid

28

out of 100

Grade: F

Growth: 7.3Profit: 2.0Value: 5.0Quality: 5.0
Piotroski: 4/9Altman Z: -0.65
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CCLDUndervalued (+65.8%)

Margin of Safety

+65.8%

Fair Value

$6.55

Current Price

$2.05

$4.50 discount

UndervaluedFair: $6.55Overvalued

Intrinsic value data unavailable for TEM.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCLD2 strengths · Avg: 9.0/10
PEG RatioValuation
0.3110/10

Growing faster than its price suggests

Revenue GrowthGrowth
16.4%8/10

16.4% revenue growth

TEM1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
21.6%8/10

Revenue surging 21.6% year-over-year

Areas to Watch

CCLD4 concerns · Avg: 3.3/10
P/E RatioValuation
29.3x4/10

Moderate valuation

Market CapQuality
$87.11M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
6.2%3/10

6.2% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

TEM4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Price/BookValuation
23.9x2/10

Trading at 23.9x book value

Return on EquityProfitability
-57.2%2/10

ROE of -57.2% — below average capital efficiency

Free Cash FlowQuality
$-18.62M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : CCLD

The strongest argument for CCLD centers on PEG Ratio, Revenue Growth. Revenue growth of 16.4% demonstrates continued momentum. PEG of 0.31 suggests the stock is reasonably priced for its growth.

Bull Case : TEM

The strongest argument for TEM centers on Revenue Growth. Revenue growth of 21.6% demonstrates continued momentum.

Bear Case : CCLD

The primary concerns for CCLD are P/E Ratio, Market Cap, Profit Margin. Debt-to-equity of 3.10 is elevated, increasing financial risk.

Bear Case : TEM

The primary concerns for TEM are EPS Growth, Price/Book, Return on Equity. Debt-to-equity of 3.25 is elevated, increasing financial risk.

Key Dynamics to Monitor

TEM carries more volatility with a beta of 3.72 — expect wider price swings.

TEM is growing revenue faster at 21.6% — sustainability is the question.

CCLD generates stronger free cash flow (7M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CCLD scores higher overall (51/100 vs 28/100) and 16.4% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CareCloud, Inc.

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

CareCloud, Inc., a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. The company is headquartered in Somerset, New Jersey.

Visit Website →

Tempus AI, Inc. Class A Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Tempus AI, Inc is a healthcare technology company. The company is headquartered in Chicago, Illinois.

Visit Website →

Want to dig deeper into these stocks?